See # 10 research article...none of our people inv
Post# of 148183
In addition See PLOS Pathogens Published 03-31-2022...abstract states;
"Our results demonstrate that weekly, self-administered Leronlimab was SAFE, well-tolerated and efficacious for long-term SUPPRESSION and treatment for people living with HIV-1". It is stated clearly... Zero equivocation...by men and women of science
There were 14 authors including Dr. Jonah Sacha.
Why???... are we still "On hold".